AOR SoluFibre

AOR Advantage
AOR’s SoluFibre contains partially hydrolyzed guar gum, a highly soluble, easy to take, digestion resistant form of fibre that imparts no flavor or texture change to the foods it’s added to. It has been studied in clinical trials, it has been found to have the greatest range of beneficial results and health applications, and it has been found to be the most tolerable form of fibre for children due to its lack of flavour and texture-changing characteristics.

Discussion
SoluFibre contains Sunfiber®, a soluble fibre derived from guar bean gum. Sunfiber® improves intestinal/bowel regularity and provides gentle relief of constipation in the general population as well as in people with irritable bowel syndrome (IBS). Helps relieve minor gastrointestinal symptoms associated with IBS.

Guarantees
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, corn, nuts, peanuts, sesame seeds, sulphites, mustard, soy, dairy, eggs, fish, shellfish or any animal by product.

Disclaimer
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.

Supplement Facts
Serving Size:One Scoop (~5 g)


Sunfiber® (partially hydrolyzed guar gum: 5 g
Sunfiber® is a registered trademark of Taiyo International Inc.
Non-medicinal Ingredients: none.

Adult Dosage
Take one to two scoops daily, children over nine take one scoop daily. Take two hours before or after taking other medications, or as directed by a qualified health care practitioner. For each scoop, mix with 200 ml of liquid (water, milk, fruit juice or similar aqueous beverage). Stir briskly and drink immediately. Maintain adequate fluid intake.
Cautions
Consult a health care practitioner prior to use, if you are pregnant or breastfeeding, if you are taking medications which inhibit peristaltic movement (e.g. opioids, loperamide), or if you are experiencing any of the following; sudden change in bowel habits that have persisted for more than two weeks, undiagnosed rectal bleeding, failure to defecate following the use of laxative products, diabetes mellitus in which blood sugar is difficult to regulate, or symptoms such as abdominal pain, nausea, vomiting, or fever. If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner.